MIRXES-B (02629) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Discuss Final Dividend

Bulletin Express
03/19

Mirxes Holding Company Limited (stock code: 02629, abbreviated as “MIRXES-B”) announced that its board of directors will convene on Tuesday, 31 March 2026.

Key agenda items include: 1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025. 2. Authorising the publication of the FY2025 results. 3. Considering a recommendation for a final dividend, if any. 4. Addressing other routine business matters.

Board composition as of the announcement date (19 March 2026) comprises: • Executive Directors: Dr. ZHOU Lihan (also Chief Executive Officer) and Dr. ZOU Ruiyang. • Non-executive Directors: Dr. TOO Heng Phon, Dr. LE Beilin and Mr. LIU Da. • Independent Non-executive Directors: Dr. LAM Sin Lai Judy, Mr. FANG Xiao and Ms. MA Andrea Lo Ling.

The meeting outcome will shape MIRXES-B’s disclosure schedule for its FY2025 performance and signal potential shareholder returns via a final dividend proposal.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10